Amgen announced a change to the national drug code for its osteoporosis drug, Prolia.
Amgen Announces NDC Change for Osteoporosis Drug
Drugmaker Amgen announced a change to the national drug code (NDC) for its osteoporosis drug, Prolia. The California-based drug giant [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.